Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > More evidence ! PMX & Covid-19

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Sep 09, 2022 11:14am

225 Views

Post# 34952160

RE:RE:RE:RE:More evidence ! PMX & Covid-19

MM

I'm not even sure there is continuing analyst coverage.

Unless we missed an update on The ARC and VA deals as well as FDA Breakthrough Designation.

You'd have to try really, really, really hard to remain valued as an obscure and anonymous little Canadian drug making micro cap after that string of news releases.

Really hard! But option season is coming...And they own it all!

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market